Practice Areas - Corporate and M&A Law Firms and Lawyers
| Deal Date: | 16-12-2013 | Practice Area: | Corporate and M&A |
| Deal Title: | GlaxoSmithKline Increase in Indian Subsidiary Shareholding | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Slaughter and May is advising GlaxoSmithKline on its voluntary offer, announced on 16 December 2013, to increase its stake in its publicly-listed pharmaceuticals subsidiary in India (GlaxoSmithKline Pharmaceuticals Limited) from 50.7% to up to 75%. The potential total value of the transaction at the proposed offer price is approximately GBP629 million.
Corporate and Commercial: David Johnson (partner), Robert Innes (associate).
|
||
| Financial Center: | London | Value: | 500.01-1000.00 |
| Advised Party: | Acquiror | Law Firm | Slaughter and May |
| Target Company Jurisdiction: | India | Acquiror Jurisdiction: | United Kingdom |
| Classification: |
Strategic Buyer Acquisitions Public Company - Hostile Bid |
Lawyer | David Johnson |
